Still, despite multidisciplinary treatment with surgery, radio- and chemotherapy, IDH-mutant gliomas recur and the tumors usually develop therapeutic resistance, making them incurable with current treatment [37]. This evidence concerns the gene IDH1 and central nervous system cancer.